MENU
CRNX
AS OF
Nov 13 closing price
Price
$41.43
Change
-$1.39 (-3.25%)
Capitalization
3.93B
110 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CRNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Crinetics Pharmaceuticals (CRNX) Earnings Date & Reports

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

A.I. Advisor
published Earnings

CRNX is expected to report earnings to fall 7.25% to -127 cents per share on March 04

Crinetics Pharmaceuticals CRNX Stock Earnings Reports
Q4'25
Est.
$-1.28
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.13
Q1'25
Missed
by $0.11
Q4'24
Est.
$-0.88
The last earnings report on November 06 showed earnings per share of -137 cents, missing the estimate of -125 cents. With 1.98M shares outstanding, the current market capitalization sits at 3.93B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CRNX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRNX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CRNX
A.I. Advisor
published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com